Company Profiles

driven by the PitchBook Platform

Mobius Therapeutics

Description

Developer of a drug for glaucoma surgery. The company provides antifibrotic agents such as mitomycin-c to ophthalmic surgeons which can be used during glaucoma, refractive, and corneal surgeries.

2006

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$5M

Latest Deal Amount

$9.3M

Total Amount Raised

Description

Developer of a drug for glaucoma surgery. The company provides antifibrotic agents such as mitomycin-c to ophthalmic surgeons which can be used during glaucoma, refractive, and corneal surgeries.

Website:

www.mobiustherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Surgical Devices

Primary Office

1000 Executive Parkway Suite 224 Saint Louis, MO 63141United States +1 (314) 615-6930
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Mobius Therapeutics's full profile, request a free trial.

    Mobius Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Mobius Therapeutics Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Accelerate St LouisAccelerator/IncubatorMinority000 0000000 0000
    BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
    Compass Group Equity PartnersPE/BuyoutMinority000 0000000 0000
    Cultivation CapitalVenture CapitalMinority000 0000000 0000
    National Institute on Deafness and Other Communication DisordersGovernment000 0000000 0000
    Accelerate St Louis Accelerator/Incubator
    BioGenerator Not-For-Profit Venture Capital
    Compass Group Equity Partners PE/Buyout
    Cultivation Capital Venture Capital
    National Institute on Deafness and Other Communication Disorders Government

    Mobius Therapeutics Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Ed TimmPresident, Chief Executive Officer, Board Member & Founder
    Mark WrightChief Financial Officer
    Carla TimmDirector of Operations, Customer Service, Sales Support and Marcom
    Alan BeckmanDirector of Regulatory Affairs/Quality Assurance
    Kate NortonDirector of Supply Chain and Controller
    Ed Timm President, Chief Executive Officer, Board Member & Founder
    Mark Wright Chief Financial Officer
    Carla Timm Director of Operations, Customer Service, Sales Support and Marcom
    Alan Beckman Director of Regulatory Affairs/Quality Assurance
    Kate Norton Director of Supply Chain and Controller

    Mobius Therapeutics Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Dean VandeKampCultivation CapitalGeneral Partner000 0000
    Dean VandeKamp General Partner Cultivation Capital
    Request full access to PitchBook